Navigation Links
HemoShear Relocates and Expands Operations to Historic Martha Jefferson Property in Charlottesville, Virginia
Date:1/22/2013

CHARLOTTESVILLE, Va., Jan. 22, 2013 /PRNewswire/ -- HemoShear LLC, a biotechnology research company and leading developer of human-relevant systems for drug development and discovery, today announced that it will expand and relocate its operations to downtown Charlottesville, Virginia.  The Company will initially lease 14,800 square feet of the Cardwell Building in the historic former Martha Jefferson Hospital, now owned by Octagon Partners.  The lease allows for expansion to additional floors, as HemoShear's business requires.

(Logo: http://photos.prnewswire.com/prnh/20120416/PH86899LOGO)

HemoShear has grown to more than 30 employees since launching operations in 2009.  The Company continues to expand its customer base, which includes most major biopharmaceutical companies, by deploying its human-relevant systems and scientific expertise to reduce new drug R&D costs and improve success rates of new drug candidates. In 2012, HemoShear received the Rocket Award from the Charlottesville Business Innovation Council for rapid commercialization of a new technology.  

The renovated Cardwell space will allow for continued growth as HemoShear increases the scope of its pharmaceutical customer partnerships and its technology development.  Nicole Hastings , Ph.D., Vice President of Operations, said, "The Cardwell Building has an ideal infrastructure. The new space allows us to design for improved workflow, optimal productivity and quality.  We are also excited to be located near all of the downtown Charlottesville activities and to contribute to the growth of the Charlottesville bioscience community."

Demolition for the new space is underway and HemoShear is actively planning for its move to the Cardwell Building in mid-2013.  Mark Mascotte of MFM Partners, LLC, represented the landlord in the lease transaction.  StellarOne Bank and the Commonwealth of Virginia provided financial assistance to HemoShear. Local contractor Vision Building & Design, LLC will perform the demolition, design and space outfit. 

About HemoShear LLC 
HemoShear creates human-relevant systems that accurately replicate the biology of organ systems and diseases for drug discovery and development. Working in strategic partnerships with pharmaceutical, biotechnology and medical device companies, HemoShear generates meaningful data to increase confidence in decision-making, reduce risk of costly failures and identify efficacious therapies.  HemoShear's science leads to new medicines and improves human health.  

 


'/>"/>
SOURCE HemoShear LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. HemoShear Adds Industry Veterans Mehmood Khan and Fred Brown to Board of Managers
2. HemoShear Unveils In Vitro Steatosis System at Annual Meeting of the Association for the Study of Liver Diseases
3. HemoShear Publishes Key Review on Human-Relevant Organotypic Systems
4. Sysmex America Relocates Corporate Headquarters
5. ImmusanT Relocates Offices to State-of-the-Art Innovation Facility
6. Ultragenyx Relocates Company Headquarters to Support Operational Expansion
7. AAIPharma Expands Laboratory Service Offerings and Capabilities in its Technology Center
8. Concentra Expands Medical Services within the Dallas-Fort Worth area
9. AssureRx Health Expands Management Team to Support Increasing Business Growth
10. Cumberland Emerging Technologies Expands Life Sciences Center
11. VWR International, LLC Expands European Portfolio With Acquisitions Of Labonord SAS And Switch BVBA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... CITY , March 29, 2017  Bodycad ... and Drug Administration (FDA) 510(k) clearance for its ... of this truly personalized orthopaedic restoration. Bodycad is ... for a joint reconstruction implant system. ... to optimize personalized restoration of the patient,s unique ...
(Date:3/29/2017)... Global intravenous (IV) iron and oral iron market ... at a CAGR of 5%. Iron drugs ... treat anemia or other iron deficiencies. Oral iron supplements are ... in some cases, oral administrations are not capable of maintaining ... therapy comes into the picture. Global Intravenous (IV) ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "Italy ... report to their offering. ... Proton Therapy Market in Italy will double by ... currently three proton therapy centers in Italy that ... Italy , the first patients were treated with proton beams in ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... 2017 , ... Wells Pharmacy Network, a proud A4M Platinum ... World Congress, in Hollywood Florida April 6-8, 2017. , Ben David, CEO of ... in the training of physicians, scientists, and members of the public on anti-aging ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... in Carnegie, OK, from Dr. Jamie Cameron, with or without a referral. ... to traditional orthodontic treatment. Depending on each patient’s case, treatment with the FASTBRACES ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... documenting and diagramming network and data center assets and audio-video devices has recently ... request new equipment shapes for free and download shapes and stencils from ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... many scientific laboratories. The assembly protocols involve many repetitive steps and often scientists ... automation, which enables the high-throughput needed, and results in a lower error rate ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... Gastrointestinal Oncology™ (SOGO™), a specialized continuing medical education conference for clinicians who manage ... Intercontinental Time Square, New York. , The program will be led by ...
Breaking Medicine News(10 mins):